drug-testing
(2)
Sus Clinicals, Inc.
Sus Clinicals, Inc. is a Cincinnati- and Chicago-based biotechnology company commercializing the Oncopig Cancer Model - a genetically engineered pig that develops human-like tumors on demand. Billed as the only FDA-cleared large animal cancer platform, the Oncopig carries KRAS and TP53 mutations found in more than half of human cancers, giving drug, device, and diagnostic developers a predictive testing ground that sits between the mouse and the human clinical trial. Alongside live animal supply, the company runs histology services and a tumor-tissue biorepository, and partners with CROs across the US and Europe.
KarmaCheck
KarmaCheck is an AI-driven background check and credentialing platform that makes employment screening faster, cheaper, and more accurate. Founded in 2019 by LinkedIn co-founder and founding CTO Eric Ly, the company combines real-time identity verification, criminal and credential checks, drug screening, and occupational health into an API-first platform that plugs into the ATS, HRIS, and HCM systems staffing and healthcare teams already use. In 2025 it launched the industry's first MCP server, letting AI agents run verifications through plain-language prompts.